Intratumoral NK cells were typically CD16-low, consistent with other studies (Figure 3a,b) and there was no relationship between tumor MHC-I expression and NK cell content, with effector CD8 T cells remaining predominant in MHC-I low tumors (Figure 3c). The gene discussed is CD8A; the disease is neoplasm.